Gene · 3816
Papers1,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema. | J Med Chem | 2022 | 36251573 | PubTator, text mining | PubMed |
| The rationale for the treatment of long-Covid symptoms - A cardiologist's view. | Front Cardiovasc Med | 2022 | 36186977 | PubTator, text mining | PubMed |
| Corneodesmosin as a potential target of oral squamous cell carcinoma. | Medicine (Baltimore) | 2022 | 36181011 | PubTator, text mining | PubMed |
| In Silico Prediction of Anti-Infective and Cell-Penetrating Peptides from Thalassophryne nattereri Natterin Toxins. | Pharmaceuticals (Basel) | 2022 | 36145362 | PubTator, text mining | PubMed |
| Rational Approach to Finding Genes Encoding Molecular Biomarkers: Focus on Breast Cancer. | Genes (Basel) | 2022 | 36140706 | PubTator, text mining | PubMed |
| Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. | Mol Immunol | 2022 | 36030710 | PubTator, text mining | PubMed |
| The complex role of kininogens in hereditary angioedema. | Front Allergy | 2022 | 35991308 | PubTator, text mining | PubMed |
| Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. | Sci Rep | 2022 | 35974070 | PubTator, text mining | PubMed |
| Rethinking the initial changes in subarachnoid haemorrhage: Focusing on real-time metabolism during early brain injury. | EBioMedicine | 2022 | 35973388 | PubTator, text mining | PubMed |
| Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis. | Front Immunol | 2022 | 35967373 | PubTator, text mining | PubMed |
| SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE. | Front Allergy | 2022 | 35958943 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Diabetic Kidney Disease. | Int J Mol Sci | 2022 | 35955802 | PubTator, text mining | PubMed |
| Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19. | EBioMedicine | 2022 | 35939907 | PubTator, text mining | PubMed |
The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. | Genes (Basel) | 2022 | 35885904 | PubTator, text mining | PubMed |
| Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis. | Biomolecules | 2022 | 35883559 | PubTator, text mining | PubMed |
| Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE). | Front Allergy | 2022 | 35873600 | PubTator, text mining | PubMed |
| Uterine kallikrein and arterial bradykinin activities and uterine arterial proliferation in response to acute estradiol-17β exposure in ovariectomized ewes. | Domest Anim Endocrinol | 2022 | 35842984 | PubTator, text mining | PubMed |
| Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan. | Front Cardiovasc Med | 2022 | 35811711 | PubTator, text mining | PubMed |
| Molecular genetics of pulmonary hypertension in children. | Curr Opin Genet Dev | 2022 | 35772304 | PubTator, text mining | PubMed |
| Cetacean epidermal specialization: A review. | Anat Histol Embryol | 2022 | 35758554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3816/papers?page=8